Evopoint Biosciences Co., Ltd. (SHA:688837)
China flag China · Delayed Price · Currency is CNY
33.98
-1.23 (-3.49%)
Nov 17, 2026, 3:00 PM CST

Evopoint Biosciences Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Revenue
226.69927.19--19.5
Other Revenue
8.068.06---
234.75935.24--19.5
Revenue Growth
-----
Gross Profit
234.75935.24--19.5
Selling, General & Admin
100.58215.3474.6482.4877.89
Research & Development
616.94509387.44367.61463.92
Other Operating Expenses
-14.680.790.020.070.25
Operating Expenses
702.85725.13462.1450.16542.06
Operating Income
-468.1210.11-462.1-450.16-522.56
Interest Expense
-30.78-23.87-15.89-7.78-2.95
Interest & Investment Income
11.636.967.874.1739.83
Currency Exchange Gain (Loss)
-5.2-5.20.280.266.04
Other Non Operating Income (Expenses)
-13-0.08-0.05-0.08-0.05
EBT Excluding Unusual Items
-505.45187.93-469.9-453.59-479.68
Gain (Loss) on Sale of Investments
118.83156.7359.3818.2310.5
Gain (Loss) on Sale of Assets
--00.05-0.1
Other Unusual Items
-49.4-49.3824.518.426.65
Pretax Income
-436.03295.27-386-426.89-462.63
Income Tax Expense
17.1492.72---
Net Income
-453.17202.56-386-426.89-462.63
Net Income to Common
-453.17202.56-386-426.89-462.63
Net Income Growth
-----
Shares Outstanding (Basic)
371368368342326
Shares Outstanding (Diluted)
371368368342326
Shares Change
-0.18%7.65%4.82%-
EPS (Basic)
-1.220.55-1.05-1.25-1.42
EPS (Diluted)
-1.220.55-1.05-1.25-1.42
EPS Growth
-----

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
-529.87115.66-399.57-460.68-580.75
Free Cash Flow Per Share
-1.430.31-1.09-1.35-1.78
Gross Margin
100.00%100.00%--100.00%
Operating Margin
-199.41%22.47%---2679.80%
Profit Margin
-193.05%21.66%---2372.47%
Free Cash Flow Margin
-225.72%12.37%---2978.22%
EBITDA
-435.87242.5-443.53-440.51-515.57
EBITDA Margin
-185.68%25.93%---
D&A For EBITDA
32.2332.3918.579.656.99
EBIT
-468.1210.11-462.1-450.16-522.56
EBIT Margin
-199.41%22.47%---
Effective Tax Rate
-31.40%---